IBD in the COVID-19 Era: Update for the Busy Clinician

Content Type: presentation

Presenter: Samir A. Shah, MD, FACG; Jean-Paul Achkar, MD, FACG; David T. Rubin. MD, FACG; Erica Brenner, MD; Rya C. Ungaro, MD; David P. Hudesman, MD; Sunanda V. Kane, MD, MSPH, FACG

Presenter Disclosure: Drs. Shah, Achkar, and Brenner have indicated no relevant financial relationships. David T. Rubin, MD, FACG: Advisory Committee/Board Member: CCFA, Janssen; Consultant: AbbVie Pharmaceuticals, Abgenomics, Allergan, Biomica, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Check-cap, Dizal Pharmaceuticals, Galen Pharma/Atlantica, Genentech, Gilead Sciences, Ichnos Sciences S.A. (formerly Glenmark Pharmaceuticals), GSK, Janssen, Lilly, Narrow River Mgmt., Pfizer, Prometheus, Reistone, Shire, Takeda, Techlab, Inc.; Employee: Cornerstones Health Inc. (non-profit medical education company), GoDuRn LLC (non-profit medical education company); Grant/Research Support: AbbVie Pharmaceuticals, Genentech, Janssen, Prometheus Laboratories, Shire, Takeda; Co-Founder: Cornerstones Health Inc. (non-profit medical education company), GoDuRn LLC (non-profit medical education company); Royalties: Slack Publications Ryan C. Ungaro, MD: Grant Support: NIH K23 Career Development Award (K23KD111995-01A1); Advisory Board/Consultant: Eli Lilly, Janssen, Pfizer, Takeda; Research Support: AbbVie, Boehringer Ingelheim, Pfizer David P. Hudesman, MD: Consulting - Abbvie, BMS, Janssen, Pfizer, Takeda; Research support - Pfizer Sunanda V. Kane, MD, MSPH, FACG: Consultant: Gilead, Samsung Bioepis

Event: ACG Virtual Grand Rounds

Release Date: 5/15/2020

Expiration Date: 5/15/2023

Objective: Describe how best to manage patients with chronic conditions like Inflammatory Bowel Diseases (Crohn's Disease and Ulcerative Colitis) during the COVID-19 pandemic, including how to best manage medical treatments that suppress or modify the immune system.